Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer. | J Pers Med | 2021 | 33806972 | PubTator, text mining | PubMed |
| Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype. | Cancers (Basel) | 2021 | 33804155 | PubTator, text mining | PubMed |
| Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. | J Clin Med | 2021 | 33801181 | PubTator, text mining | PubMed |
| Identification of Overexpressed Genes in Malignant Pleural Mesothelioma. | Int J Mol Sci | 2021 | 33800494 | PubTator, text mining | PubMed |
| NMR Characterization of the Interactions Between Glycosaminoglycans and Proteins. | Front Mol Biosci | 2021 | 33796549 | PubTator, text mining | PubMed |
| Identification and development of an independent immune-related genes prognostic model for breast cancer. | BMC Cancer | 2021 | 33785008 | PubTator, text mining | PubMed |
| Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics. | J Proteome Res | 2021 | 33780252 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Identifies Ligand-Receptor Pairs Associated With BCP-ALL Prognosis. | Front Oncol | 2021 | 33777800 | PubTator, text mining | PubMed |
| A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration. | Front Mol Biosci | 2021 | 33748185 | PubTator, text mining | PubMed |
Long non-coding RNA maternally expressed gene 3 affects cell proliferation, apoptosis and migration by targeting the microRNA-9-5p/midkine axis and activating the phosphoinositide-dependent kinase/AKT pathway in hepatocellular carcinoma. | Oncol Lett | 2021 | 33747202 | PubTator, text mining | PubMed |
| Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers. | Front Oncol | 2021 | 33718169 | PubTator, text mining | PubMed |
| Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults. | Front Immunol | 2021 | 33717192 | PubTator, text mining | PubMed |
In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. | Front Pharmacol | 2021 | 33716737 | PubTator, text mining | PubMed |
| Estimation of Serum Midkine in Oral Squamous Cell Carcinoma and Oral Premalignancy. | Gulf J Oncolog | 2021 | 33716209 | PubTator, text mining | PubMed |
| Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia. | Front Oncol | 2021 | 33708624 | PubTator, text mining | PubMed |
| Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis. | Biomed Res Int | 2021 | 33688500 | PubTator, text mining | PubMed |
| NETosis as a Pathogenic Factor for Heart Failure. | Oxid Med Cell Longev | 2021 | 33680285 | PubTator, text mining | PubMed |
| Nucleolin acts as the receptor for C1QTNF4 and supports C1QTNF4-mediated innate immunity modulation. | J Biol Chem | 2021 | 33676896 | PubTator, text mining | PubMed |
| Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment. | NPJ Breast Cancer | 2021 | 33674617 | PubTator, text mining | PubMed |
| Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma. | Biomedicines | 2021 | 33670230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=60